Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(66.7%)
N/A
1(33.3%)
3Total
Phase 3(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03554226Not ApplicableCompleted

Agitation and Aggressivity in Alzheimer's Disease Patients: A Cohort Study

Role: collaborator

NCT04679142Unknown

Baclocur® Post-Authorisation Safety Study in Real-life Settings in France

Role: lead

NCT01738282Phase 3Completed

Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients

Role: lead

NCT01842893Phase 3Completed

Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer

Role: lead

All 4 trials loaded